Clinical Trial Update: Effect of Weizmania Coagulans BC99 Intervention on Gut Microbiota and Metabolic Markers in Overweight/Obese Adults [NA]

View source ↗

Summary

A completed clinical trial evaluating the effects of Weizmania Coagulans BC99 on gut microbiota and metabolic markers in overweight/obese adults.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• Weizmania Coagulans BC99

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Overweight | NA | Status: COMPLETED